1 Prince M, Albanese E, Guerchet M, Prina M. World Al- zheimer report 2014: Dementia and risk reduction - An analy- sis of protective and modifiable factors [Internet]. London: Alzheimer’s Disease International; 2014 [cited 2022 May 31]. Available from: https://www.alzint.org/u/WorldAlzheimer- Report 2014.pdf
2 Selkoe DJ. The molecular pathology of Alzheimer’s disease. Neuron. 1991;6:487-98. DOI: 10.1016/0896-6273(91)90052-2, PMID: 1673054
3 Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992;256:184-5. DOI: 10.1126/ science.1566067, PMID: 1566067
4 Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297:353-6. DOI: 10.1126/science.1072994, PMID: 12130773
5 Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science. 1992;258:126-9. DOI: 10.1126/science.1439760, PMID: 1439760 Dementia prevention and aromatherapy
6 Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al. Immunization with amyloid-β attenuates Alzheimer- disease-like pathology in the PDAPP mouse. Nature. 1999;400:173-7. DOI: 10.1038/22124, PMID: 10408445
7 Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, Gonzales V, et al. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer’s disease. J Neurosci. 2005;25:5217-24. DOI: 10.1523/JNEURO- SCI.5080-04.2005, PMID: 15917461
8 Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673-734. DOI: 10.1016/S0140- 6736(17)31363-6, PMID: 28735855
9 Meng X, D’Arcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One. 2012;7:e38268. DOI: 10.1371/journal.pone.0038268, PMID:22675535
10 Vassilaki M, Aakre JA, Knopman DS, Kremers WK, Mielke MM, Geda YE, et al. Informant-based hearing difficulties and the risk for mild cognitive impairment and dementia. Age Ageing. 2019;48:888-94. DOI: 10.1093/ageing/afz099, PMID: 31437275
11 Walker KA, Power MC, Gottesman RF. Defining the relation- ship between hypertension, cognitive decline, and dementia: A review. Curr Hypertens Rep. 2017;19:24. DOI: 10.1007/ s11906-017-0724-3, PMID: 28299725
12 Pugazhenthi S, Qin L, Reddy PH. Common neurodegenera- tive pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta Mol Basis Dis. 2017;1863:1037-45. DOI: 10.1016/j.bbadis.2016.04.017, PMID: 27156888
13 Durazzo TC, Mattsson N, Weiner MW; Alzheimer’s Disease Neuroimaging Initiative. Smoking and increased Alzheimer’s disease risk: A review of potential mechanisms. Alzheimers Dement. 2014;10(suppl):S122-45. DOI: 10.1016/ j.jalz.2014.04.009, PMID: 24924665
14 Kessing LV. Depression and the r isk for dementia. Curr Opin Psychiatry. 2012;25:457-61. DOI: 10.1097/ YCO.0b013e328356c368, PMID: 22801361
15 Kivimäki M, Singh-Manoux A, Pentti J, Sabia S, Nyberg ST, Alfredsson L, et al.; IPD-Work consortium. Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis. BMJ. 2019;365:l1495. DOI: 10.1136/bmj.l1495, PMID: 30995986
16 Evans IEM, Llewellyn DJ, Matthews FE, Woods RT, Brayne C, Clare L; CFAS-Wales research team. Social isolation, cognitive reserve, and cognition in healthy older people. PLoS One. 2018;13:e0201008. DOI: 10.1371/journal.pone.0201008,PMID: 30118489
17 Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14:591-604. DOI: 10.1038/s41574-018- 0048-7, PMID: 30022099
18 Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413-46. DOI: 10.1016/S0140-6736(20)30367-6, PMID: 32738937
19 Graham NSN, Sharp DJ. Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical tri- als in dementia. J Neurol Neurosurg Psychiatry. 2019;90:1221-33. DOI: 10.1136/jnnp-2017-317557, PMID: 31542723
20 Xu W, Wang H, Wan Y, Tan C, Li J, Tan L, et al. Alcohol consumption and dementia risk: a dose–response meta- analysis of prospective studies. Eur J Epidemiol. 2017;32:31-42. DOI: 10.1007/s10654-017-0225-3, PMID: 28097521
21 Peters R, Ee N, Peters J, Booth A, Mudway I, Anstey KJ. Air pollution and dementia: A systematic review. J Alzheimers Dis. 2019;70:S145-63. DOI: 10.3233/JAD-180631, PMID: 30775976
22 Urakami K. [Prevention of dementia]. Jpn J Clin Med. 2016;74:395-8. PMID: 27025075 PMID: 27025075 Japanese with English abstract.
23 Petersen RC. Clinical practice. Mild cognitive impair- ment. N Engl J Med. 2011;364:2227-34. DOI: 10.1056/ NEJMcp0910237, PMID: 21651394
24 Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characteriza- tion and outcome. Arch Neurol. 1999;56:303-8. DOI: 10.1001/ archneur.56.3.303, PMID: 10190820
25 Ninomiya T, Nakaji S, Maeda T, Yamada M, Mimura M, Nakashima K, et al.; JPSFC-AD Study Group. Study design and baseline characteristics of a population-based prospective cohort study of dementia in Japan: the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD). Environ Health Prev Med. 2020;25:64. DOI: 10.1186/s12199- 020-00903-3, PMID: 33129280
26 Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr. 2004;16:129-40. DOI: 10.1017/S1041610204000092, PMID:15318760
27 Inoue M, Jinbo D, Nakamura Y, Taniguchi M, Urakami K. Development and evaluation of a computerized test battery for Alzheimer’s disease screening in community-based set- tings. Am J Alzheimers Dis Other Demen. 2009;24:129-35. DOI: 10.1177/1533317508330222, PMID: 19150968
28 Inoue M, Jimbo D, Taniguchi M, Urakami K. Touch Panel- type Dementia Assessment Scale: a new computer-based rating scale for Alzheimer’s disease. Psychogeriatrics. 2011;11:28-33. DOI: 10.1111/j.1479-8301.2010.00345.x, PMID:21447106
29 Urakami K. Examination and preventive intervention of dementia from the point of view of life style. Jpn J Geriatr. 2011;48:118-9. DOI: 10.3143/geriatrics.48.118, PMID:21778622
30 Ito Y, Urakami K. Evaluation of dementia-prevention classes for community-dwelling older adults with mild cognitive impairment. Psychogeriatrics. 2012;12:3-10. DOI: 10.1111/ j.1479-8301.2011.00397.x, PMID: 22416823
31 Kouzuki M, Kato T, Wada-Isoe K, Takeda S, Tamura A, Takanashi Y, et al. A program of exercise, brain training, and lecture to prevent cognitive decline. Ann Clin Transl Neurol. 2020;7:318-28. DOI: 10.1002/acn3.50993, PMID: 32068975
32 Tottori Prefecture Web Site [Internet]. Tottori: Tottori Prefecture [cited 2022 May 22]. [Dementia-related measures]. Available from: https://www.pref.tottori.lg.jp/item/1198192. htm. Japanese.
33 Silva MM, Mercer PBS, Witt MCZ, Pessoa RR. Olfactory dysfunction in Alzheimer’s disease Systematic review and meta-analysis. Dement Neuropsychol. 2018;12:123-32. DOI: 10.1590/1980-57642018dn12-020004, PMID: 29988355K. Urakami
34 Ikejima C, Hisanaga A, Meguro K, Yamada T, Ouma S, Kawamuro Y, et al. Multicentre population-based dementia prevalence survey in Japan: a preliminary report. Psychogeri- atrics. 2012;12:120-3. DOI: 10.1111/j.1479-8301.2012.00415.x, PMID: 22712646
35 Jimbo D, Inoue M, Taniguchi M, Urakami K. Specific feature of olfactory dysfunction with Alzheimer’s disease inspected by the Odor Stick Identification Test. Psychogeriatrics. 2011;11:196-204. DOI: 10.1111/j.1479-8301.2011.00387.x,PMID: 22151238
36 Kovács T, Cairns NJ, Lantos PL. Beta-Amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer’s disease. Neuropathol Appl Neurobiol. 1999;25:481-91. DOI: 10.1046/j.1365-2990.1999.00208.x,PMID: 10632898
37 Jimbo D, Kimura Y, Taniguchi M, Inoue M, UrakamiK. Effect of aromatherapy on patients with Alzheimer’s disease. Psychogeriatrics. 2009;9:173-9. DOI: 10.1111/j.1479- 8301.2009.00299.x, PMID: 20377818
38 Okuda M, Fujita Y, Takada-Takatori Y, Sugimoto H, Urakami K. Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation. PLoS One. 2020;15:e0240378. DOI: 10.1371/journal.pone.0240378, PMID: 33052945
39 Prince M, Wimo A, Guerchet M, Ali GC, Prina M. World Alzheimer report 2015: Global impact of dementia: An analysis of prevalence, incidence, cost and trends. Dementia. Alzheimer’s Disease International. 2015 September; London; 1–26.
40 Ninomiya T. [A study on future estimates of the elderly population with dementia in Japan] [Internet]. Wako: Na- tional Institute of Public Health [cited 2022 May 31]. Available from: https://mhlw-grants.niph.go.jp/system/ files/2014/141031/201405037A_upload/201405037A0003.pdf. Japanese.
論文の公開元へ
